Search results
Eli Lilly Remains an Equities Outlier
FX Empire via Yahoo Singapore Finance· 14 hours agoIt’s no wonder LLY shares are up 54% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Singapore Finance· 14 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...